List Of Drugs Susceptible To Counterfeiting Developed By National Boards Of Pharmacy
This article was originally published in The Pink Sheet Daily
Executive Summary
The list is based on one developed by the Florida Department of Health. Model licensing rules from the association would require random authentications of the pedigrees of such drugs by wholesalers.
You may also be interested in...
FDA Postpones Paper Pedigree Requirements Until December 2006
The proposal is part of the agency’s Combating Counterfeit Drugs report. FDA plans to move forward with the use of radio frequency identification technology.
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles